Log in to save to my catalogue

Comment to "Human cytomegalovirus seropositivity is associated with reduced patient survival during...

Comment to "Human cytomegalovirus seropositivity is associated with reduced patient survival during...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11134663

Comment to "Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis"

About this item

Full title

Comment to "Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis"

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2024-05, Vol.28 (1), p.182, Article 182

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Active HCMV infection should be considered when IgG levels significantly exceed the reference value by more than fourfold [4, 5]. [...]it is possible that the current study underestimated the incidence of HCMV seropositivity and reactivation. [...]the study did not detail the antiviral prophylaxis or preemptive therapy regimens of the study populat...

Alternative Titles

Full title

Comment to "Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis"

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11134663

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11134663

Other Identifiers

ISSN

1364-8535,1466-609X

E-ISSN

1466-609X,1364-8535,1366-609X

DOI

10.1186/s13054-024-04914-2

How to access this item